Ocular complications of type 1 diabetes
DOI:
https://doi.org/10.13112/pc.1065Keywords:
OPHTHALMOLOGY; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; GLAUCOMA; DRY EYE SYNDROMESAbstract
Type 1 diabetes affects millions of people worldwide and requires careful management to avoid serious long-term complications, including heart and kidney disease, stroke, and vision loss. The group of patients with type 1 diabetes is very heterogeneous, with individuals having the disease at different stages. Over 40 % of patients living with type 1 diabetes develop diabetic eye disease. Early detection and timely appropriate treatment can reduce the risk of blindness by more than 95 %.
References
1. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115(11):1859-68. doi: 10.1016/j.ophtha.2008.08.023.
2. Kernell A, Dedorsson I, Johansson B, et al. Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre study. Diabetologia. 1997;40:307–10. doi: 10.1007/s001250050683.
3. Hong Y, Hassan N, Cheah YK, et al. Management of T1DM in children and adolescents in primary care. Malays Fam Physician. 2017;12:18–22.
4. DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449–62. doi: 10.1016/S0140-6736(18)31320-5.
5. Hainsworth DP, Bebu I, Aiello LP, et al. Risk factors for retinopathy in type 1 diabetes: the DCCT/EDIC study. Diabetes Care. 2019;42(5):875–82. doi: 10.2337/dc18-2516.
6. Forga L, Goñi MJ, Ibáñez B, Cambra K, García-Mouriz M, Iriarte A. Influence of age at diagnosis and time-dependent risk factors on the development of diabetic retinopathy in patients with type 1 diabetes. J Diabetes Res. 2016;2016:1–7. doi: 10.1155/2016/9898309.
7. Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018. Diabetes Technol Ther. 2019;21(2):66–72. doi: 10.1089/dia.2018.0384.
8. Zhang X, Zhao L, Deng S, Sun X, Wang N. Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics. J Ophthalmol. 2016;2016:8201053. doi: 10.1155/2016/8201053.
9. Kuo YK, Shao SC, Lin ET, Pan LY, Yeung L, Sun CC. Tear function in patients with diabetes mellitus: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;13:1036002. doi: 10.3389/fendo.2022.1036002.
10. Binder A, Maddison PJ, Skinner P, Kurtz A, Isenberg DA. Sjögren's syndrome: Association with type-1 diabetes mellitus. Br J Rheumatol. 1989;28:518–20. doi: 10.1093/rheumatology/28.6.518.
11. Hymowitz MB, Chang D, Feinberg EB, Roy S. Increased intraocular pressure and hyperglycemic level in diabetic patients. PLoS One. 2016;11(3):e0151833. doi: 10.1371/journal.pone.0151833.
12. Ramm L, Herber R, Spoerl E, Pillunat LE, Terai N. Intraocular pressure measurements in diabetes mellitus. Eur J Ophthalmol. 2020;30(6):1432-9. doi: 10.1177/1120672120937354.
13. Zhao H, He Y, Ren YR, Chen BH. Corneal alteration and pathogenesis in diabetes mellitus. Int J Ophthalmol. 2019;12(12):1939-50. doi: 10.18240/ijo.2019.12.12.
14. Last JA, Pan T, Ding Y, et al. Elastic modulus determination of normal and glaucomatous human trabecular meshwork. Invest Ophthalmol Vis Sci. 2011;52:2147–52. doi: 10.1167/iovs.10-5785.
15. Berrabeh S, Elmehraoui O, Benouda S, Assarrar I, Rouf S, Latrech H. Prevalence and risk factors of retinopathy in type 1 diabetes: a cross-sectional study. Cureus. 2023;15(10):e47993. doi: 10.7759/cureus.47993.
16. Matuszewski W, Baranowska-Jurkun A, Stefanowicz-Rutkowska MM, Modzelewski R, Pieczyński J, Bandurska-Stankiewicz E. Prevalence of diabetic retinopathy in type 1 and type 2 diabetes mellitus patients in North-East Poland. Medicina (Kaunas). 2020;56(4):164. doi: 10.3390/medicina56040164.
17. Lundeen EA, Burke-Conte Z, Rein DB, et al. Prevalence of diabetic retinopathy in the US in 2021. JAMA Ophthalmol. 2023;141(8):747–54. doi: 10.1001/jamaophthalmol.2023.2965.
18. Maguire A, Chan A, Cusumano J, et al. The case for biennial retinopathy screening in children and adolescents. Diabetes Care. 2005;28:509–13. doi: 10.2337/diacare.28.2.509.
19. Wysocka-Mincewicz M, Gołębiewska J, Olechowski A, Szalecki M. Diabetic retinopathy in children with type 1 diabetes—occurrence and screening using optical coherence tomography. Life (Basel). 2021 Jun 21;11(6):590. doi: 10.3390/life11060590.
20. Invernizzi A, Chhablani J, Viola F, Gabrielle PH, Zarranz-Ventura J, Staurenghi G. Diabetic retinopathy in the pediatric population: Pathophysiology, screening, current and future treatments. Pharmacol Res. 2023;188:106670. doi: 10.1016/j.phrs.2023.106670.
21. King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999;48(5):643-8. doi: 10.1046/j.1365-2125.1999.00092.x.
22. Romero-Aroca P, Fernández-Balart J, Baget-Bernaldiz M, et al. Changes in the diabetic retinopathy epidemiology after 14 years in a population of type 1 and 2 diabetic patients. J Diabetes Complications. 2009;23(4):229-38. doi: 10.1016/j.jdiacomp.2008.02.003.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ana Vučinović, Željana Matutinović Odak, Darko Batistić
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Paediatria Croatica, authors retain the copyright to their work and grant others the right to use, reproduce, and share their research articles in accordance with the Creative Commons Attribution License (CC BY 4.0), which allows others to distribute and build upon the work as long as they credit the author for the original creation.
